-
Je něco špatně v tomto záznamu ?
The Immunomodulatory Potential of Mesenchymal Stem Cells in a Retinal Inflammatory Environment
B. Hermankova, J. Kossl, P. Bohacova, E. Javorkova, M. Hajkova, M. Krulova, A. Zajicova, V. Holan,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 2005-03-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2005-03-01 do Před 1 rokem
- MeSH
- antivirové látky farmakologie MeSH
- cytokiny metabolismus MeSH
- imunomodulace účinky léků imunologie MeSH
- interferon gama farmakologie MeSH
- interleukin-1beta farmakologie MeSH
- mediátory zánětu farmakologie MeSH
- mezenchymální kmenové buňky cytologie metabolismus MeSH
- myši inbrední C57BL MeSH
- myši MeSH
- oxid dusnatý metabolismus MeSH
- retina cytologie účinky léků imunologie metabolismus MeSH
- TNF-alfa farmakologie MeSH
- zánět imunologie metabolismus patologie prevence a kontrola MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Retinal degenerative disorders are characterized by a local upregulation of inflammatory factors, infiltration with cells of the immune system, a vascular dysfunction and by the damage of retinal cells. There is still a lack of treatment protocols for these diseases. Mesenchymal stem cell (MSC)-based therapy using immunoregulatory, regenerative and differentiating properties of MSCs offers a promising treatment option. In this study, we analyzed the immunomodulatory properties of mouse bone marrow-derived MSCs after their intravitreal delivery to the inflammatory environment in the eye, caused by the application of pro-inflammatory cytokines IL-1β, TNF-α and IFN-γ. The intravitreal administration of these cytokines induces an increased expression of pro-inflammatory molecules such as IL-1α, IL-6, inducible nitric oxide synthase, TNF-α and vascular endothelial growth factor in the retina. However, a significant decrease in the expression of genes for all these pro-inflammatory molecules was observed after the intravitreal injection of MSCs. We further showed that an increased infiltration of the retina with immune cells, mainly with macrophages, which was observed after pro-inflammatory cytokine application, was significantly reduced after the intravitreal application of MSCs. The similar immunosuppressive effects of MSCs were also demonstrated in vitro in cultures of cytokine-stimulated retinal explants and MSCs. Overall, the results show that intravitreal application of MSCs inhibits the early retinal inflammation caused by pro-inflammatory cytokines, and propose MSCs as a promising candidate for stem cell-based therapy of retinal degenerative diseases.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025466
- 003
- CZ-PrNML
- 005
- 20201222155217.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12015-019-09908-0 $2 doi
- 035 __
- $a (PubMed)31863334
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hermankova, Barbora $u Department of Transplantation Immunology, Institute of Experimental Medicine of the Czech Academy of Sciences, 142 20, Prague 4, Czech Republic.
- 245 14
- $a The Immunomodulatory Potential of Mesenchymal Stem Cells in a Retinal Inflammatory Environment / $c B. Hermankova, J. Kossl, P. Bohacova, E. Javorkova, M. Hajkova, M. Krulova, A. Zajicova, V. Holan,
- 520 9_
- $a Retinal degenerative disorders are characterized by a local upregulation of inflammatory factors, infiltration with cells of the immune system, a vascular dysfunction and by the damage of retinal cells. There is still a lack of treatment protocols for these diseases. Mesenchymal stem cell (MSC)-based therapy using immunoregulatory, regenerative and differentiating properties of MSCs offers a promising treatment option. In this study, we analyzed the immunomodulatory properties of mouse bone marrow-derived MSCs after their intravitreal delivery to the inflammatory environment in the eye, caused by the application of pro-inflammatory cytokines IL-1β, TNF-α and IFN-γ. The intravitreal administration of these cytokines induces an increased expression of pro-inflammatory molecules such as IL-1α, IL-6, inducible nitric oxide synthase, TNF-α and vascular endothelial growth factor in the retina. However, a significant decrease in the expression of genes for all these pro-inflammatory molecules was observed after the intravitreal injection of MSCs. We further showed that an increased infiltration of the retina with immune cells, mainly with macrophages, which was observed after pro-inflammatory cytokine application, was significantly reduced after the intravitreal application of MSCs. The similar immunosuppressive effects of MSCs were also demonstrated in vitro in cultures of cytokine-stimulated retinal explants and MSCs. Overall, the results show that intravitreal application of MSCs inhibits the early retinal inflammation caused by pro-inflammatory cytokines, and propose MSCs as a promising candidate for stem cell-based therapy of retinal degenerative diseases.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antivirové látky $x farmakologie $7 D000998
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a imunomodulace $x účinky léků $x imunologie $7 D056747
- 650 _2
- $a zánět $x imunologie $x metabolismus $x patologie $x prevence a kontrola $7 D007249
- 650 _2
- $a mediátory zánětu $x farmakologie $7 D018836
- 650 _2
- $a interferon gama $x farmakologie $7 D007371
- 650 _2
- $a interleukin-1beta $x farmakologie $7 D053583
- 650 _2
- $a mezenchymální kmenové buňky $x cytologie $x metabolismus $7 D059630
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a retina $x cytologie $x účinky léků $x imunologie $x metabolismus $7 D012160
- 650 _2
- $a TNF-alfa $x farmakologie $7 D014409
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kossl, Jan $u Department of Transplantation Immunology, Institute of Experimental Medicine of the Czech Academy of Sciences, 142 20, Prague 4, Czech Republic. Department of Cell Biology, Faculty of Science, Charles University, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Bohacova, Pavla $u Department of Transplantation Immunology, Institute of Experimental Medicine of the Czech Academy of Sciences, 142 20, Prague 4, Czech Republic. Department of Cell Biology, Faculty of Science, Charles University, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Javorkova, Eliska $u Department of Transplantation Immunology, Institute of Experimental Medicine of the Czech Academy of Sciences, 142 20, Prague 4, Czech Republic. Department of Cell Biology, Faculty of Science, Charles University, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Hajkova, Michaela $u Department of Transplantation Immunology, Institute of Experimental Medicine of the Czech Academy of Sciences, 142 20, Prague 4, Czech Republic. Department of Cell Biology, Faculty of Science, Charles University, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Krulova, Magdalena $u Department of Transplantation Immunology, Institute of Experimental Medicine of the Czech Academy of Sciences, 142 20, Prague 4, Czech Republic. Department of Cell Biology, Faculty of Science, Charles University, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Zajicova, Alena $u Department of Transplantation Immunology, Institute of Experimental Medicine of the Czech Academy of Sciences, 142 20, Prague 4, Czech Republic.
- 700 1_
- $a Holan, Vladimir $u Department of Transplantation Immunology, Institute of Experimental Medicine of the Czech Academy of Sciences, 142 20, Prague 4, Czech Republic. vladimir.holan@iem.cas.cz. Department of Cell Biology, Faculty of Science, Charles University, 128 43, Prague 2, Czech Republic. vladimir.holan@iem.cas.cz.
- 773 0_
- $w MED00205753 $t Stem cell reviews and reports $x 2629-3277 $g Roč. 15, č. 6 (2019), s. 880-891
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31863334 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222155212 $b ABA008
- 999 __
- $a ok $b bmc $g 1599611 $s 1116152
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 15 $c 6 $d 880-891 $e - $i 2629-3277 $m Stem cell reviews and reports $n Stem Cell Rev Rep $x MED00205753
- LZP __
- $a Pubmed-20201125